Cenova Capital

A Central Player in China’s Healthcare Transformation Headquartered in Shanghai, Cenova Capital is one of the earliest healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sectors in China Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies

Cenova has a differentiated strategy of investing in life sciences and healthcare by leveraging its healthcare services portfolio to access adjacent opportunities in the healthcare products and services sub-sector As a value oriented investor, Cenova uses a methodical, research based approach to uncover unique proprietary investment opportunities and has built a synergistic, highly profitable healthcare services portfolio in IVF, maternity, ENT, ophthalmology and aesthetics / plastic surgery

Shaped by our core values of integrity, respect, teamwork and diligence and our twin principles of putting the interests of our customers first and our commitment to performance and returning capital to our investors, we aim to be the leading healthcare fund in China and be the partner of choice for investors and healthcare companies interested in capturing the unprecedented growth in China healthcare